Page last updated: 2024-11-02

pamidronate and Carcinoma, Epidermoid

pamidronate has been researched along with Carcinoma, Epidermoid in 13 studies

Research Excerpts

ExcerptRelevanceReference
"Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life."5.31[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer]. ( Hashitani, S; Matsushita, Y; Nishimura, N; Noguchi, K; Takaoka, K; Urade, M, 2002)
"Autopsy specimens of a bone metastasis from a woman with a primary squamous cell carcinoma of the tongue who developed multiple osteolytic lesions and hypercalcemia and was treated with pamidronate were studied histologically, histochemically, and ultrastructurally."3.69Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model. ( Hiraga, T; Nakajima, T; Ozawa, H; Takada, M, 1996)
"Hypercalcemia is a common complication of malignancy and portends a worse prognosis."1.40Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy. ( Pani, A; Reagan, P; Rosner, MH, 2014)
"Pamidronate was well tolerated and only grade 1 or 2 toxicities were registered."1.35Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis. ( Mitterer, M; Seeber, A; Spizzo, G, 2009)
"Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life."1.31[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer]. ( Hashitani, S; Matsushita, Y; Nishimura, N; Noguchi, K; Takaoka, K; Urade, M, 2002)
"Hypercalcemia was defined as a serum Ca concentration higher than 11 mg/dl of the correction for serum albumin concentration."1.31Hypercalcemia in patients with oral squamous cell carcinoma. ( Iwase, M; Kakuta, S; Kurachi, Y; Nagumo, M; Nakamura-Mitsuhashi, M; Sakamaki, H, 2001)
"A 57-year-old man with lung squamous cell carcinoma revealed hypercalcemia, hypophosphoremia, elevation of nephrogenous cAMP and metabolic alkalosis."1.29A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia. ( Haji, M; Hara, N; Ichinose, Y; Iguchi, H; Katakami, H; Nawata, H; Nishi, Y; Ohta, M; Tanaka, S, 1993)
"Malignant hypercalcemia is caused by both increased bone resorption and enhanced tubular reabsorption of calcium."1.28Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone. ( Burckhardt, P; Jaeger, P; Thiebaud, D, 1990)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (38.46)18.2507
2000's6 (46.15)29.6817
2010's2 (15.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arif, H1
Beg, M1
Zahid, S1
Sial, M1
Talwar, A1
Christou, A1
Babich, M1
Reagan, P1
Pani, A1
Rosner, MH1
Spizzo, G1
Seeber, A1
Mitterer, M1
Nishimura, N1
Matsushita, Y1
Takaoka, K1
Hashitani, S1
Noguchi, K1
Urade, M1
Yoshiike, F1
Koizumi, T1
Yoneyama, A1
Komatu, M1
Yamaguchi, S1
Hanaoka, M1
Kubo, K1
Eda, S1
Ramadan, KM1
McKenna, KE1
Morris, TC1
Mundy, GR1
Iguchi, H2
Katakami, H1
Ichinose, Y1
Nishi, Y1
Tanaka, S1
Hara, N1
Ohta, M1
Haji, M1
Nawata, H1
Hiraga, T1
Takada, M1
Nakajima, T1
Ozawa, H1
Endo, K1
Katsumata, K1
Kubodera, N1
Teramoto, T1
Ikeda, K1
Fujita, T1
Ogata, E1
Bileckot, R1
Touazi, S1
Auvinet, B1
Le Lain, JC1
Iwase, M1
Kurachi, Y1
Kakuta, S1
Sakamaki, H1
Nakamura-Mitsuhashi, M1
Nagumo, M1
Thiebaud, D1
Jaeger, P1
Burckhardt, P1

Reviews

1 review available for pamidronate and Carcinoma, Epidermoid

ArticleYear
Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.
    Journal of gastrointestinal cancer, 2019, Volume: 50, Issue:4

    Topics: Calcitonin; Calcium; Calcium-Regulating Hormones and Agents; Carcinoma, Squamous Cell; Cinacalcet; D

2019

Other Studies

12 other studies available for pamidronate and Carcinoma, Epidermoid

ArticleYear
Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2014, Volume: 63, Issue:1

    Topics: Aged; Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; Carcinoma, Squamous C

2014
Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis.
    Anticancer research, 2009, Volume: 29, Issue:12

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ad

2009
[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:13

    Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Consciousness Disorders; Diphosphonates; Dru

2002
Thymic squamous cell carcinoma producing parathyroid hormone-related protein and CYFRA 21-1.
    Internal medicine (Tokyo, Japan), 2004, Volume: 43, Issue:6

    Topics: Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; C

2004
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
    The Lancet. Oncology, 2006, Volume: 7, Issue:11

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bor

2006
Evaluation and treatment of hypercalcemia.
    Hospital practice (Office ed.), 1994, Jun-15, Volume: 29, Issue:6

    Topics: Adenoma; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Diphosphonates; Fe

1994
A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia.
    Japanese journal of cancer research : Gann, 1993, Volume: 84, Issue:4

    Topics: Blotting, Northern; Carcinoma, Squamous Cell; Chromatography, Gel; Diagnosis, Differential; Diphosph

1993
Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1996, Volume: 54, Issue:11

    Topics: Acid Phosphatase; Aged; Animals; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Diphosph

1996
Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1998, Volume: 13, Issue:9

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Calcitriol

1998
[Analgesic effect of Pamidronate on bone pain in patient with hypertrophic pulmonary osteoarthropathy].
    Revue de pneumologie clinique, 2001, Volume: 57, Issue:3

    Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Diphosphonates; Drug Admi

2001
Hypercalcemia in patients with oral squamous cell carcinoma.
    Clinical oral investigations, 2001, Volume: 5, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Calcitonin; Carcinoma, Squamous Cell; Diphosphona

2001
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1990, Volume: 5, Issue:3

    Topics: Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Female; Humans;

1990